122 related articles for article (PubMed ID: 8971799)
41. Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.
Maggio R; Scarselli M; Novi F; Millan MJ; Corsini GU
J Neurochem; 2003 Nov; 87(3):631-41. PubMed ID: 14535946
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and binding properties of several new dopaminergic ligands.
Tuce Z; Soskić V; Joksimović J
Drug Des Discov; 1994 Jun; 11(4):251-8. PubMed ID: 7727678
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
Piercey MF; Hoffmann WE; Smith MW; Hyslop DK
Eur J Pharmacol; 1996 Sep; 312(1):35-44. PubMed ID: 8891576
[TBL] [Abstract][Full Text] [Related]
44. Prominent binding of the dopamine D3 agonist [3H]PD 128907 in the caudate-putamen of the adult rat.
Hillefors M; von Euler M; Hedlund PB; von Euler G
Brain Res; 1999 Mar; 822(1-2):126-31. PubMed ID: 10082890
[TBL] [Abstract][Full Text] [Related]
45. [3H](+)-7-OH-DPAT and [3H]pramipexole binding in the striatum and nucleus accumbens of Sprague-Dawley and Fischer-344 rats.
Wallace DR; Owens J; Booze RM
Life Sci; 1998; 63(19):PL275-80. PubMed ID: 9806230
[TBL] [Abstract][Full Text] [Related]
46. Pramipexole upregulates dopamine receptor D₂ and D₃ expression in rat striatum.
Tokunaga N; Choudhury ME; Nishikawa N; Nagai M; Tujii T; Iwaki H; Kaneta M; Nomoto M
J Pharmacol Sci; 2012; 120(2):133-7. PubMed ID: 22986363
[TBL] [Abstract][Full Text] [Related]
47. The effect of repeated treatment with pramipexole on the central dopamine D3 system.
Maj J; Rogói Z; Margas W; Kata M; Dziedzicka-Wasylewska M
J Neural Transm (Vienna); 2000; 107(12):1369-79. PubMed ID: 11458990
[TBL] [Abstract][Full Text] [Related]
48. Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies.
Morissette M; Goulet M; Grondin R; Blanchet P; Bédard PJ; Di Paolo T; Lévesque D
Eur J Neurosci; 1998 Aug; 10(8):2565-73. PubMed ID: 9767387
[TBL] [Abstract][Full Text] [Related]
49. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: a receptor binding and quantitative autoradiographic study.
Bancroft GN; Morgan KA; Flietstra RJ; Levant B
Neuropsychopharmacology; 1998 Apr; 18(4):305-16. PubMed ID: 9509498
[TBL] [Abstract][Full Text] [Related]
50. Modulation of [3H]quinpirole binding at striatal D2 dopamine receptors by a monoamine oxidaseA-like site: evidence from radioligand binding studies and D2 receptor- and MAO(A)-deficient mice.
Levant B; Morgan KA; Ahlgren-Beckendorf JA; Grandy DK; Chen K; Shih JC; Seif I
Life Sci; 2001 Nov; 70(2):229-41. PubMed ID: 11787947
[TBL] [Abstract][Full Text] [Related]
51. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
Luedtke RR; Freeman RA; Boundy VA; Martin MW; Huang Y; Mach RH
Synapse; 2000 Dec; 38(4):438-49. PubMed ID: 11044891
[TBL] [Abstract][Full Text] [Related]
52. A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist.
Black KJ; Hershey T; Koller JM; Videen TO; Mintun MA; Price JL; Perlmutter JS
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17113-8. PubMed ID: 12482941
[TBL] [Abstract][Full Text] [Related]
53. Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study.
Schotte A; Janssen PF; Bonaventure P; Leysen JE
Histochem J; 1996 Nov; 28(11):791-9. PubMed ID: 8968731
[TBL] [Abstract][Full Text] [Related]
54. [Quantitative autoradiographic analysis of the binding of mosapramine to dopamine D3-receptors].
Futamura T; Shimokawa T; Morio Y; Haga K; Fukuda T
Nihon Yakurigaku Zasshi; 1995 Nov; 106(5):339-46. PubMed ID: 8566910
[TBL] [Abstract][Full Text] [Related]
55. Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain.
Gehlert DR; Gackenheimer SL; Seeman P; Schaus J
Eur J Pharmacol; 1992 Feb; 211(2):189-94. PubMed ID: 1351846
[TBL] [Abstract][Full Text] [Related]
56. Pharmacological characterisation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney.
Barili P; Ricci A; Baldoni E; Mignini F; Amenta F
Eur J Pharmacol; 1997 Oct; 338(1):89-95. PubMed ID: 9408008
[TBL] [Abstract][Full Text] [Related]
57. [Interaction of simple tetrahydroisoquinolines with opiate and high-affinity dopamine (D3) receptors in the rat corpus striatum].
Patsenko AA; Grinevich VP; Ostrovskiĭ IuM
Farmakol Toksikol; 1987; 50(4):33-5. PubMed ID: 2822473
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of (+)-7-hydroxy-N,N-di-n-[3H]propyl-2-aminotetralin binding following intracerebroventricular administration of a nitric oxide generator.
Wallace DR; Booze RM
Neurochem Res; 1997 Feb; 22(2):163-70. PubMed ID: 9016841
[TBL] [Abstract][Full Text] [Related]
59. High affinity dopamine receptors (D3) in rat brain.
Titeler M; List S; Seeman P
Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
[No Abstract] [Full Text] [Related]
60. Regional CNS densities of monoamine receptors in alcohol-naive alcohol-preferring P and -nonpreferring NP rats.
McBride WJ; Chernet E; Russell RN; Wong DT; Guan XM; Lumeng L; Li TK
Alcohol; 1997; 14(2):141-8. PubMed ID: 9085714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
